JAMES BROWN: Open Payments
NPI 1942754650 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Abbott Laboratories | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Boston Scientific Corporation | 1 | $25 |
| PROTEGA PHARMACEUTIALS INC | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Valinor Pharma, LLC | 1 | $15 |
Products named: Senza, RELISTOR, PROCLAIM, XTAMPZA, Clinical Trial Product, ROXYBOND, AJOVY, MOVANTIK.
Industry payments across TX — which companies pay providers there.
